Concepedia
Statistics
Publications
4
Citations
155
H-Index
Active since
2013
Affiliations
Inserm(Current)
Institut pour l'avancée des biosciences
Centre National de la Recherche Scientifique
Université Claude Bernard Lyon 1
Université Joseph Fourier
Anastassia Karageorgis is an author at Inserm specializing in medicine, oncology, and molecular imaging.
Publications per year
2013–2018
An MRI-based classification scheme to predict passive access of 5 to 50-nm large nanoparticles to tumors
Anastassia Karageorgis, Sandrine Dufort, Lucie Sancey et al. · Scientific Reports · 2016 · 58 citations · Full text
Medicine, Biomedical Engineering, Oncology +17
The dual effect of mesenchymal stem cells on tumour growth and tumour angiogenesis
Michelle Kéramidas, Florence de Fraipont, Anastassia Karageorgis et al. · Stem Cell Research & Therapy · 2013 · 55 citations · Full text
Medicine, Cancer Biology, Oncology +10
A multi-center preclinical study of gadoxetate DCE-MRI in rats as a biomarker of drug induced inhibition of liver transporter function
Anastassia Karageorgis, Stephen C. Lenhard, Brittany Yerby et al. · PLoS ONE · 2018 · 22 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +17
Systemic Delivery of Tumor-Targeted Bax-Derived Membrane-Active Peptides for the Treatment of Melanoma Tumors in a Humanized SCID Mouse Model
Anastassia Karageorgis, Michaël Claron, Romain Jugé et al. · Molecular Therapy · 2017 · 20 citations · Full text
Pharmacy, Cancer Biology, Oncology +16
1–4 of 4